The effect of patent ductus arteriosus on coronary artery blood flow in premature infants: a prospective observational pilot study

J Perinatol. 2020 Sep;40(9):1366-1374. doi: 10.1038/s41372-020-0622-4. Epub 2020 Feb 20.

Abstract

Objective: To compare coronary flows between premature infants with and without hemodynamically significant patent ductus arteriosus (hsPDA) and to determine if coronary flow is influenced by medical PDA treatment.

Design: Prospective, observational pilot study. Forty-three infants <32 weeks gestation underwent echocardiography when routinely indicated. Study group included infants with hsPDA requiring treatment. Comparison groups included infants with nonsignificant PDA and infants without PDA.

Results: The study group (n = 13), compared with the comparison groups with nonsignificant PDA (n = 12) and without PDA (n = 18) had higher troponin levels (p = 0.003 and 0.004, respectively). In infants with hsPDA compared with infants with no PDA there was a significant increase in myocardial oxygen demand and decrease in left main coronary artery flow, with nonsignificant increase in cardiac output.

Conclusions: Decrease in coronary artery flows and higher troponin values may suggest a "steal effect," not allowing to meet the elevated myocardial oxygen demand in infants with hsPDA.

Publication types

  • Observational Study

MeSH terms

  • Coronary Vessels
  • Ductus Arteriosus, Patent* / diagnostic imaging
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Premature
  • Pilot Projects
  • Prospective Studies